Rep. Gilbert Cisneros Buys Novanta (NOVT) Stock
Gilbert Cisneros buys shares of Novanta Inc. as part of his recent investment activity.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Gilbert Cisneros bought between $1,001 and $15,000 of Novanta Inc. ($NOVT) stock on May 18, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed June 9, 2026.
Since the trade, $NOVT is up 8.0% after 1 week, up 0.1% after 1 month and down 14.9% to date (from the $151.27 close on May 18, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Gilbert Cisneros (D-CA)
- Status:
- Member — House
- State/District:
- CA-31
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Jun 9, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Novanta Inc. ($NOVT) | Buy | May 18, 2026 | $1,001 - $15,000 |
Summary of the filed report, not the original document. Find the original: House financial disclosure search
Key Points
- Gilbert Cisneros purchased shares of Novanta Inc. (NOVT) valued between $1,001 and $15,000 on May 18, 2026.
- The stock traded at $162.41 on the day of the transaction, up from a previous close of $133.14.
- This buy adds to Cisneros's recent activity, including purchases of shares in other companies like Sensata Technologies and STERIS.
Get $NOVT trade alerts by text
We text you when insiders, Congress or big funds trade $NOVT. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Novanta Inc. alert may contain errors. Disclosures
Gilbert Cisneros Expands Holdings with NOVT Purchase
Gilbert Cisneros, a U.S. House member, bought shares of Novanta Inc. (NOVT) on May 18, 2026, valued between $1,001 and $15,000. This transaction was disclosed on June 9, 2026, when the stock was trading at $162.41 on the NasdaqGS exchange, up from a prior close of $133.14.
Gilbert Cisneros vs. the S&P 500
Hypothetical returns from Gilbert Cisneros's disclosed trades, not real profit or advice. How we model this.
Recent Purchase Fits a Pattern
This latest purchase adds to Cisneros's recent investment activity. He has been active in the market, with previous disclosures showing he bought Sensata Technologies shares on the same day he made this purchase. In total, this is his third reported buy in May alone, following acquisitions of shares in STERIS and Veralto Corporation.
How NOVT Stock Has Traded
As of the reported date, NOVT's shares are trading at $162.41, which is well above its 52-week low of $98.27 and close to its 52-week high of $176.38. This indicates that the stock has been performing strongly, reflecting investor interest and confidence in the company's future prospects.
What NOVT Does
Novanta Inc. specializes in precision medicine, manufacturing, and medical technologies. The Bedford, Massachusetts-based company provides solutions for robotics and automation, serving various sectors including healthcare and advanced manufacturing. Given its focus on innovative technologies, Cisneros's investment may reflect his belief in the company's growth potential.
What’s Next for Cisneros
Looking ahead, Gilbert Cisneros's investment activities will be worth monitoring, especially as he continues to disclose purchases under the STOCK Act. The next earnings report for Novanta Inc. is scheduled for November 3, 2026, which could influence future trading decisions by investors, including Cisneros. As a reminder, this transaction reflects his holdings as of May 18, 2026, and may not represent his current position.
Source: Gilbert Cisneros's STOCK Act disclosure on $NOVT (May 18, 2026). Find the original filing: House financial disclosure search. Written by software, not financial advice. How we make alerts
